Ji Young Yhee

Title: Ji Young Yhee: Innovator in Tumor-Targeted Delivery Systems

Introduction

Ji Young Yhee is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the efficacy of gene silencing techniques for cancer treatment.

Latest Patents

Ji Young Yhee holds a patent for a "Gelatin-based nanoparticle complex for tumor-targeted delivery of siRNA and method for preparing the same." This invention involves a gelatin-based nanoparticle complex designed for the specific delivery of siRNA to tumor cells, facilitating targeted gene silencing. The complex comprises poly-siRNA chains modified with thiol groups and thiolated gelatin, which are linked through disulfide crosslinking and charge interactions. Notably, this nanoparticle complex remains stable in the bloodstream and is efficiently absorbed by tumor cells without causing cytotoxicity. The siRNA delivered can effectively silence target gene expression, showcasing a promising advancement in cancer therapy.

Career Highlights

Ji Young Yhee is affiliated with the Korea Institute of Science and Technology, where she continues to push the boundaries of research in drug delivery systems. Her innovative approach has garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies.

Collaborations

Ji Young Yhee has collaborated with notable colleagues, including Ick Chan Kwon and Kwang Meyung Kim. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.

Conclusion

Ji Young Yhee's contributions to the field of tumor-targeted delivery systems exemplify her commitment to advancing cancer treatment. Her innovative patent and collaborative efforts position her as a key figure in biomedical research.